Roche’s COVID drugs tumble $1B as new eye launch Vabysmo rushes to counter biosimilar-hit Lucentis FiercePharma
source
Chat read-only to anonymous users. Chat with Anyone and Anywhere. Only registered users are allowed to send messages.
28726
Register Login